These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 32332598)

  • 21. Postoperative Radiotherapy in Pathological T2-3N0M0 Thoracic Esophageal Squamous Cell Carcinoma: Interim Report of a Prospective, Phase III, Randomized Controlled Study.
    Deng W; Yang J; Ni W; Li C; Chang X; Han W; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Wang X; Wang X; Deng L; Wang W; Bi N; Zhang T; Li Y; Gao S; Xue Q; Mao Y; Sun K; Liu X; Fang D; Wang D; Li J; Zhao J; Shao K; Li Z; Chen X; Han L; Wang L; He J; Xiao Z
    Oncologist; 2020 Apr; 25(4):e701-e708. PubMed ID: 32083766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection.
    Chen J; Wu S; Zheng X; Pan J; Zhu K; Chen Y; Li J; Liao L; Lin Y; Liao Z
    BMC Surg; 2014 Dec; 14():110. PubMed ID: 25527100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A retrospective study of postoperative radiotherapy for locally advanced esophageal squamous cell carcinoma.
    Zhang Z; Xu L; Di X; Zhang C; Ge X; Sun X
    Ann Palliat Med; 2019 Nov; 8(5):708-716. PubMed ID: 31865731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma?
    Chen G; Wang Z; Liu XY; Liu FY
    Ann Thorac Surg; 2009 Jun; 87(6):1697-702. PubMed ID: 19463580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nomogram to Predict Overall Survival for Thoracic Esophageal Squamous Cell Carcinoma Patients After Radical Esophagectomy.
    Deng W; Zhang W; Yang J; Ni W; Yu S; Li C; Chang X; Zhou Z; Chen D; Feng Q; Chen X; Lin Y; Zhu K; Zheng X; He J; Gao S; Xue Q; Mao Y; Cheng G; Sun K; Liu X; Fang D; Chen J; Xiao Z
    Ann Surg Oncol; 2019 Sep; 26(9):2890-2898. PubMed ID: 31183641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of radiotherapy interruption on esophageal cancer with intensity-modulated radiotherapy: a retrospective study.
    Mou Y; Liang P; Cheng X; He X; Zhang J; Liu L; Liu Q
    BMC Cancer; 2024 May; 24(1):646. PubMed ID: 38802765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.
    Fu X; Li T; Dai Y; Li J
    BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of different surgical approaches on the prognosis of patients with postoperative radiotherapy for stage IIB-IVA esophageal squamous cancer.
    Gao M; Zhu Y; Gu Y; Shi Z; Wu J; Chang H; Song J
    World J Surg Oncol; 2022 Aug; 20(1):271. PubMed ID: 36038943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of bilateral supraclavicular postoperative radiotherapy in middle and lower thoracic esophageal carcinoma.
    Ren Y; Su C; Zhou Y; Zhao X; Yang CL; Liu YY
    World J Gastroenterol; 2014 Dec; 20(47):17970-5. PubMed ID: 25548496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prognostic influence of preoperative Nutritional Risk Screening -2002 (NRS-2002) score for patients with thoracic esophageal squamous cell carcinoma receiving surgery].
    Sun HJ; Guo XW; Ji SJ; Zhou SB; Gu L
    Zhonghua Zhong Liu Za Zhi; 2018 Dec; 40(12):917-921. PubMed ID: 30605983
    [No Abstract]   [Full Text] [Related]  

  • 31. Relative tumor volume is a better independent prognostic factor in esophageal squamous cell carcinoma: Results of a retrospective study.
    Lv J; Gan H; Zhang W; Pan L; Wang R; Qin Y
    Medicine (Baltimore); 2019 Apr; 98(14):e14963. PubMed ID: 30946321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Factors affecting on long-time survival in patients with stage Ⅲ thoracic esophageal carcinoma after esophagectomy].
    Yang Q; Wang YX; He M; Li J; Qi Z; Zhu SC; Qiao XY
    Zhonghua Zhong Liu Za Zhi; 2016 Jul; 38(7):530-7. PubMed ID: 27531268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognostic analysis of cervical lymph node metastasis in patients with thoracic esophageal squamous cell carcinoma].
    Chen J; Zhu K; Zheng X; Chen M; Lin Y; Pan C; Pan J
    Zhonghua Zhong Liu Za Zhi; 2014 Aug; 36(8):612-6. PubMed ID: 25430029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salvage treatment for lymph node recurrence after radical resection of esophageal squamous cell carcinoma.
    Chen J; Yin W; Yao H; Gu W
    Radiat Oncol; 2019 Sep; 14(1):169. PubMed ID: 31533757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pattern of recurrence and prognostic factors in patients with pT1-3 N0 esophageal squamous cell carcinoma after surgery: analysis of a single center experience.
    Lin G; Liu H; Li J
    J Cardiothorac Surg; 2019 Mar; 14(1):58. PubMed ID: 30866983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant radiotherapy for patients with pathologic node-negative esophageal carcinoma: A population based propensity matching analysis.
    Gao HJ; Shang XB; Gong L; Zhang HD; Ren P; Shi GD; Wei YC; Yu ZT
    Thorac Cancer; 2020 Feb; 11(2):243-252. PubMed ID: 31828980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Value of postoperative radiochemotherapy for thoracic esophageal squamous cell carcinoma with lymph node metastasis].
    Lin Y; Chen J; Li J; Liu J; Zhu K; Pan C; Chen M; Pan J
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):151-4. PubMed ID: 24796467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of pathologically assessing extranodal extension in the thoracic field on the prognosis of esophageal squamous cell carcinoma.
    Okada N; Daiko H; Kanamori J; Sato A; Horikiri Y; Sato T; Fujiwara H; Tomioka T; Fujita T; Kojima T; Fujii S
    Surgery; 2019 Jun; 165(6):1203-1210. PubMed ID: 30850155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns and timing of recurrence in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy plus esophagectomy.
    Nagaki Y; Motoyama S; Sato Y; Wakita A; Fujita H; Sasaki Y; Imai K; Minamiya Y
    BMC Cancer; 2021 Nov; 21(1):1192. PubMed ID: 34753448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.